Prasad Kulkarni on a vaccine against typhoid

from Listen to The Lancet · host The Lancet

Prasad Kulkarni joins Callam Davidson of The Lancet to discuss the safety and immunogenicity of a bivalent conjugate vaccine against typhoid and paratyphoid, following the publication of a phase 1 trial.

Episode metadata supplied by the publisher feed · Published May 3, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

Prasad Kulkarni on a vaccine against typhoid

0:00 18:06

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Listen to The Lancet?

This episode is 18 minutes long.

When was this Listen to The Lancet episode published?

This episode was published on May 3, 2024.

Can I download this Listen to The Lancet episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!